231 related articles for article (PubMed ID: 27666934)
21. MicroRNA: Promising Roles in Cancer Therapy.
Hashemi A; Gorji-Bahri G
Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
Ortholan C; Puissegur MP; Ilie M; Barbry P; Mari B; Hofman P
Curr Med Chem; 2009; 16(9):1047-61. PubMed ID: 19275611
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
[TBL] [Abstract][Full Text] [Related]
27. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
Lai X; Eberhardt M; Schmitz U; Vera J
Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in melanoma biology.
Kunz M
Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA dysregulation in uveal melanoma: a new player enters the game.
Li Z; Yu X; Shen J; Jiang Y
Oncotarget; 2015 Mar; 6(7):4562-8. PubMed ID: 25682876
[TBL] [Abstract][Full Text] [Related]
31. Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.
Vergani E; Di Guardo L; Dugo M; Rigoletto S; Tragni G; Ruggeri R; Perrone F; Tamborini E; Gloghini A; Arienti F; Vergani B; Deho P; De Cecco L; Vallacchi V; Frati P; Shahaj E; Villa A; Santinami M; De Braud F; Rivoltini L; Rodolfo M
Oncotarget; 2016 Jan; 7(4):4428-41. PubMed ID: 26684239
[TBL] [Abstract][Full Text] [Related]
32. miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
Wang HF; Chen H; Ma MW; Wang JA; Tang TT; Ni LS; Yu JL; Li YZ; Bai BX
Oncol Rep; 2013 Jul; 30(1):520-6. PubMed ID: 23670160
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
34. miRNA genetic alterations in human cancers.
Giannakakis A; Coukos G; Hatzigeorgiou A; Sandaltzopoulos R; Zhang L
Expert Opin Biol Ther; 2007 Sep; 7(9):1375-86. PubMed ID: 17727327
[TBL] [Abstract][Full Text] [Related]
35. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
36. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
38. New insight into the role of miRNAs in leukemia.
Zhang H; Chen Y
Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
[TBL] [Abstract][Full Text] [Related]
39. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
